Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

VBI Vaccines Inc (VBIV)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow VBI Vaccines's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.574 -0.025    -4.24%
27/04 - Closed. Currency in USD ( Disclaimer )
After Hours
0.588
+0.014
+2.439%
9:11:52 - Real-time Data
  • Volume: 183,427
  • Bid/Ask: 0.550 / 0.600
  • Day's Range: 0.560 - 0.600
Type:  Equity
Market:  United States
VBI Vaccines 0.574 -0.025 -4.24%

VBI Vaccines Inc Company Profile

 
Get an in-depth profile of VBI Vaccines Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

135

Equity Type

ORD

VBI Vaccines Inc., a commercial-stage biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. The company also develops VBI-2601, a protein based immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study to treat solid tumors; VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial; and VBI-2501 that is in preclinical trial to treat Zika virus. In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905. The company has collaboration and license agreements with Brii Biosciences Limited; and the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is based in Cambridge, Massachusetts.

Contact Information

Address 160 Second Street Floor 3
Cambridge, 02142
United States
Phone 617 830 3031
Fax -

Top Executives

Name Age Since Title
Steven S. Gillis 70 2016 Independent Chairperson of the Board
Jeffery R. Baxter 62 2016 President, CEO & Director
Peter A. Patriarca - 2018 Member of Scientific Advisory Board
Nell Beattie 35 2015 CFO, Head of Corporate Development & Director
Eddy A. Bresnitz - 2020 Member of Commercial Advisory Board
Blaine H. McKee 58 2019 Independent Director
Daniel Shouval - 2018 Member of Scientific Advisory Board
Damian A. Braga 67 2020 Chairperson of the Commercial Advisory Board & Independent Director
Nadia G. Tornieporth - 2018 Member of Scientific & Clinical Advisory Board
Stefan Thoelen - 2018 Member of Scientific Advisory Board
Allen Waziri - 2018 Member of Scientific & Clinical Advisory Board
Stanley A. Plotkin 90 - Member of Scientific Advisory Board
Michel De Wilde 74 2016 Independent Director and Chair of Scientific & Clinical Advisory Boards
Patrick Yung Wen - 2018 Member of Scientific & Clinical Advisory Board
Pierre Van Damme - 2018 Member of Scientific Advisory Board
John D. Grabenstein - 2020 Member of Commercial Advisory Board
Denis R. Burger 79 - Member of Scientific Advisory Board
Michael D. Decker - 2020 Member of Commercial Advisory Board
Adam Finn - 2018 Member of Scientific Advisory Board
Robert Pass - 2018 Member of Scientific Advisory Board
Joanne Cordeiro 65 2019 Independent Director
Michael Lim - 2018 Member of Scientific & Clinical Advisory Board
Bruce Smith - 2018 Member of Scientific Advisory Board
Vaughn B. Himes 62 2023 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

VBIV Comments

Write your thoughts about VBI Vaccines Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email